Donaldson Capital Management, Llc
Source: SEC Form 13F · as of Mar 2026Donaldson Capital Management, Llc holds 14 biotech & pharma companies tracked by BioSniper, totaling $333.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$333.8M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 482,055 | $104.8M |
| MRKMerck & Co., Inc. | 785,160 | $94.4M |
| LLYELI LILLY & Co | 73,963 | $68.0M |
| CORCencora Inc. | 138,088 | $43.4M |
| JNJJOHNSON & JOHNSON | 34,445 | $8.4M |
| BMYBRISTOL MYERS SQUIBB CO | 65,027 | $3.9M |
| AMGNAMGEN INC | 8,320 | $2.9M |
| GILDGILEAD SCIENCES, INC. | 17,167 | $2.4M |
| ABTABBOTT LABORATORIES | 18,252 | $1.9M |
| PFEPFIZER INC | 49,305 | $1.4M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 3,094 | $837K |
| NVONovo Nordisk A/S | 15,418 | $567K |
| MCKMcKesson Corporation | 490 | $424K |
| ELVElevance Health Inc. | 1,234 | $361K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.